Aarti Pharmalabs has inaugurated new state-of-the-art additional manufacturing block at Tarapur Unit 5, Maharashtra to expand its production capacity. The company has successfully obtained all the necessary permissions and approvals to start the facility. This block has a total capacity of 3600 TPA for Xanthine derivatives manufacturing, taking its total capacity to 9600 TPA, thereby placing it amongst top 3 Xanthine derivatives manufacturers globally. This new manufacturing block emphasizes a commitment towards the company’s growth and capability development to cater to large customers’ needs.
Aarti Pharmalabs (APL) (Formerly known as Aarti Organics) is a leading Indian manufacturer of Pharmaceuticals and Nutraceuticals with a global footprint.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1865.60 |
| Dr. Reddys Labs. | 1338.00 |
| Cipla | 1450.25 |
| Zydus Lifesciences | 1109.00 |
| Lupin | 2396.60 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: